Short Summary of Edward Griffin's book about Laetrile/Amygdalin, "World Without Cancer." Some quotes have been taken from Ralph Moss's book "The Cancer Industry."
People have heard that Laetrile or Amygdalin was thoroughly tested and found to be worthless. Let us take a look. The longest and most famous Laetrile tests ever performed were run for nearly five years at Americas most prestigious cancer research center, Sloan Memmorial Kettering Cancer Research Center in New York. At the conclusion of the trials, on June 15, 1977 they released a press statement. On the Dais were physicians with impeccable credentials. �The press release said,

"...laetrile was found to possess neither preventative, nor tumor-regressent, nor anti-metastatic, nor curative anticancer activity."

So that is it then, right? It does not get more adamant than that, we can close the book on Laetrile. Unfortunately for the boss' at Sloan Kettering there was a large fly in the ointment. When a journalist asked Dr. Kenamatsu Sugiura;

"Do you stick by your belief�that laetrile stops the spread of cancer?
He replied; "I stick."

Those two words must have been like knives to the accumulated demi-gods on the dais. The reason being is that Dr. Kanematsu Sugiura was the pre-eminent cancer researcher in America, probably the world, at this time. Dr. Sugiura had been researching cancer since 1911. He was employed at Sloan-Kettering from 1917 until his official retirement in 1962. It looked as if this quiet, highly respected researcher would slip quietly into anonymity. About ten years later, in the fall of 1972 he was asked by Sloan-Kettering to test Amygdalin. Dr. Sugiura agreed.As Ralph Moss says in
"The Cancer Industry";

"Because he had merely done what he was told and recorded what he saw, he lived to see old friends desert and berate him, a close relative fail to support him, and former colleagues derisively question his sanity and competence."

Dr. Sugiura said, "The most interesting part is metastases. Secondary cancer growth to another location. When this mammary tumor grows to about two centimeters in diameter or more, about 80% develop lung metastases. But with treatment with amygdalin, it's cut down to about 20%."

He also found good results in a preventative experiment. There are particular strains of mice that are certain to get cancer in about 80/85% during a lifetime of two to two and a half years. At 18 months the mice injected with amygdalin had a 20% incidence of cancer. The saline injected control group had 50% incidence of cancer. For the first time in 60 years of cancer research people were questioning Dr. Suigara's results. Dr. Sugiura was asked why the powers that be were against laetrile;

"Why are they so much against it"? Dr Suigara answered "I don't know. Maybe the medical profession doesn't like it because they are making too much money."

They didn't like it. Sugiura had to be proven wrong. But other researchers had obtained essentially the same positive results. Dr. Lloyd Schloen a biochemist at Sloan-Kettering had included proteolytic enzymes to his injections and
reported 100% cure rate among his albino mice. This data had to be buried. They then then changed the protocols of the tests and amounts of Laetrile to make certain that they failed. Guess what, they failed, and that is what they reported.

Sloan-Ketterings motives were clearly revealed in the minutes of a meetingthat top officials held on July 2, 1974. The discussions were private and candid. The only reason we know about them is that Representative John Kelsey, of the Michigan House of Representatives, obtained the minutes via a freedom of information act request some years later. �The fact that numerous Sloan-Kettering officials were convinced of the effectiveness of amygdalin is obvious, they just weren't sure as to the extent of it's use. But they were not interested in further testing of this natural product. From
"World Without Cancer"; The minutes read, quote,

"...Sloan-Kettering is not enthusiastic about studying amygdalin but would like to study CN (cyanide) releasing drugs."

Sloan-Kettering wanted a man-made patentable chemical to mimic the qualities found in amygdalin. That is where the money is. If a very effective cancer treatment or cure was found in the lowly apricot seed, it would spell economic disaster for the cancer industry.

Author Ralph Moss worked at Sloan-Kettering during the amygdalin trials and went public on November 18, 1977, exposing the lies told by Sloan-Kettering about the amygdalin trials. He was fired the next day.���
BACK TO OLD SITE MAP
Edward Griffin's book may be purchased from his website, www.realityzone.com, amazon.com or other websites.

BACK TO NEW SITE INDEX

Please click here and spread the word
by emailing people a link to my website.

Email Me

Please help make a difference and inform people about the Cancer Racket.

Three children denied the best treatment

"A picture paints a thousand words."

Post a comment, criticism, praise, ideas etc. on my message board . (My message board is hosted by another website. In order to save you the bother of going to a totally different website, clicking will open another web-browser on your computer showing the message board. When you have posted a message, simply close the new web-browser window. There are also some pop-up ads that have nothing to do with me, just close them. To quickly place a new message, click on "General Board", then click on "New Thread." Fill out the "Subject" and put in any "Name". There are many clever functions available that you are probably already familiar with. If not, experiment. NO PROFANITY OR SPAMMING OF ANY KIND. I look forward to chatting with you there. Gavin.)

 

Hosted by www.Geocities.ws

1